Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: J Neuropathol Exp Neurol. 2011 Apr;70(4):281–291. doi: 10.1097/NEN.0b013e31821284e9

Figure 6.

Figure 6

Isoflurane induces a decrease in levels of endogenous RhoA in immature primary astroglia. Isoflurane treatment at day-in-vitro (DIV) 4 (3% for 24 hours) causes a decrease of approximately 75% in the protein content of endogenous RhoA when measured at DIV7 (2 days post-treatment) (*p < 0.01; n = 4 per data point). Experimental cultures were compared with age-matched sham control cultures (noted as 100%). Corresponding representative Western blots are shown below the graph.

HHS Vulnerability Disclosure